Announcements Trials

Browse Landscape

Phase

Status

Completed 18 Terminated 7 Unknown 3 Withdrawn 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1

Interventions

pembrolizumab 551 Specimen Handling 465 Carboplatin 441 Magnetic Resonance Spectroscopy 430 Cyclophosphamide 412 Cisplatin 397 Radiotherapy 313 Gemcitabine 309 Bevacizumab 307 Paclitaxel 294 Biopsy 261 Drug Therapy 249 Capecitabine 242 Oxaliplatin 239 fludarabine 237 Nivolumab 224 venetoclax 219 Injections 213 Docetaxel 205 Fluorouracil 203 Dexamethasone 187 Radiosurgery 172 Rituximab 158 Pemetrexed 153 Standard of Care 146 durvalumab 143 Leucovorin 139 atezolizumab 138 toripalimab 134 tislelizumab 134

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × Modafinil × Clear all

NCT05333250 2026-01-13

MODIFY

Ottawa Hospital Research Institute

Phase 1/2 Recruiting

Fatigue, Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡